Clinical trial
Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction
NCT00006062 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00006062 |
|---|---|
| Title | Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction |
| Official title | Phase I Study of Oxaliplatin in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Liver Disease |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Enrollment | 60 |
| Start date | Jul 1, 2000 |
| Completion | May 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: